Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page

Gita Taasoobshirazi

Department of Data Science and Analytics, Kennesaw State University, Kennesaw, Georgia, United States

Publications
  • Case Report   
    A Case Report: Antibody Response to 2-Dose Pfizer Vaccine and Johnson and Johnson Vaccine in a Kidney Transplant Patient
    Author(s): Gita Taasoobshirazi*, Shiva Zaman and Katayun Taasoobshirazi

    Recent research has shown that immunocompromised individuals are less likely to build detectible SARS-CoV-2 spike protein antibodies after vaccination. This is distressing for the 11.5 million individuals on some form of immunosuppressive therapy as the SARS-CoV-2 virus can lead to more severe illness and greater risk for death among these individuals. This study fills a gap in the research on COVID-19 vaccination in immunocompromised individuals with a case study of how a kidney transplant patient responded to a series of COVID-19 vaccines. The case study presented in this paper introduces the vaccination schedule and antibody testing of a kidney transplant patient in effort to assess the efficacy of a series of SARS-CoV-2 vaccines. The patient did not make SARS-CoV-2 spike protein antibodies, as assessed by a Spike Protein IgG Antibody blood test, after a two-do.. View more»

    DOI: 10.35248/2157-7560.22.13.470

    Abstract HTML PDF